Unveiling 6 Analyst Insights On Capricor Therapeutics
Unveiling 6 Analyst Insights On Capricor Therapeutics
揭示了6條關於capricor therapeutics的分析師見解。
Analysts' ratings for Capricor Therapeutics (NASDAQ:CAPR) over the last quarter vary from bullish to bearish, as provided by 6 analysts.
過去一個季度，6位分析師對Capricor Therapeutics (NASDAQ:CAPR)的評級從看好到看淡各不相同。
The table below provides a concise overview of recent ratings by analysts, offering insights into the changing sentiments over the past 30 days and drawing comparisons with the preceding months for a holistic perspective.
下表提供了分析師最近的評級概述，爲了全面了解過去30天的情緒變化並與前幾個月進行比較，提供了深入的見解。
The 12-month price targets, analyzed by analysts, offer insights with an average target of $27.83, a high estimate of $40.00, and a low estimate of $8.00. A negative shift in sentiment is evident as analysts have decreased the average price target by 8.45%.
經過分析師的評估，12個月的目標價位提供了有價值的參考意見，平均目標價爲27.83美元，最高估計爲40.00美元，最低估計爲8.00美元。由於分析師將平均目標價下調了8.45％，因此情緒出現了負面的變化。
Understanding Analyst Ratings: A Comprehensive Breakdown
分析師評級：全面解析
In examining...
通過...
登入免費觀看全文
登入/註冊